We are live on ! Find out more
AKRO

Akero Therapeutics
AKRO

Delisted

AKRO was delisted on the 8th of December, 2025.

Back to rankings

257 hedge funds and large institutions have $4.92B invested in Akero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 87 increasing their positions, 87 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $100M | Put options by funds: $48.2M

46% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 39

40% more capital invested

Capital invested by funds: $3.5B → $4.92B (+$1.41B)

23% more funds holding in top 10

Funds holding in top 10: 13 → 16 (+3)

7% more funds holding

Funds holding: 240 → 257 (+17)

7.02% more ownership

Funds ownership: 108.56% → 115.58% (+7%)

0% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 87

Holders
257
Holders Change
+17
Holders Change %
+7.08%
% of All Funds
3.38%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.21%
New
57
Increased
87
Reduced
87
Closed
39
Calls
$100M
Puts
$48.2M
Net Calls
+$51.8M
Net Calls Change
+$37.2M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$159M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$100M
3
WP
Woodline Partners
California
+$90.3M
4
Holocene Advisors
Holocene Advisors
New York
+$48.9M
5
Bank of America
Bank of America
North Carolina
+$48.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$115M
2
RI
RTW Investments
New York
-$88.2M
3
SG Americas Securities
SG Americas Securities
New York
-$52.3M
4
Citadel Advisors
Citadel Advisors
Florida
-$33.6M
5
BlackRock
BlackRock
New York
-$21.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
226
IFP Advisors
Florida
$8.38K +$318 +7 +5%
RIL
227
Rothschild Investment LLC
Illinois
$8K +$1.82K +40 +36%
APW
228
Aventura Private Wealth
Florida
$6.99K – – –
SWA
229
SOA Wealth Advisors
New York
$5.44K – – –
Bessemer Group
230
Bessemer Group
New Jersey
$5K – – –
CIAM
231
Caitong International Asset Management
Hong Kong
$4.75K -$1.54K -34 -28%
Comerica Bank
232
Comerica Bank
Texas
$4.7K -$3.5K -77 -47%
EWA
233
EverSource Wealth Advisors
Alabama
$4.64K +$772 +17 +24%
PTC
234
Private Trust Company
Ohio
$4.11K -$1.59K -35 -31%
Jones Financial Companies
235
Jones Financial Companies
Missouri
$2.81K +$2.27K +50 New
Northwestern Mutual Wealth Management
236
Northwestern Mutual Wealth Management
Wisconsin
$2.77K +$2.36K +52 New
PFBT
237
Parkside Financial Bank & Trust
Missouri
$2.67K +$909 +20 +67%
TCOT
238
Trust Company of Toledo
Ohio
$2.67K +$2.27K +50 New
PWA
239
Physician Wealth Advisors
Utah
$2.35K +$2K +44 New
CAM
240
Clarity Asset Management
Iowa
$2.24K – – –
BIA
241
Bell Investment Advisors
California
$2.08K +$1.27K +28 +255%
JSAM
242
J. Safra Asset Management
New York
$2.08K +$1.77K +39 New
MCM
243
MAI Capital Management
Ohio
$1.66K +$1.41K +31 New
HI
244
Harbour Investments
Wisconsin
$1.6K – – –
W
245
WealthCollab
Washington
$1.44K +$1.23K +27 New
MAWAG
246
Mid-American Wealth Advisory Group
Missouri
$960 +$818 +18 New
BTI
247
Blue Trust Inc
Georgia
$694 – – –
CIBC Private Wealth Group
248
CIBC Private Wealth Group
Georgia
$694 +$591 +13 New
RWM
249
Rialto Wealth Management
New York
$641 +$545 +12 New
FFA
250
Farther Finance Advisors
California
$587 +$500 +11 New
8 9
10
11 12

AKRO Hedge Fund Activity: Q2 2025 in Review

257 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Akero Therapeutics (AKRO) for Q2 2025, worth a combined $4.92B — up 40% from $3.5B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AKRO positions and 39 closed out — a net gain of 18 holders — while 87 added to existing stakes and 87 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $159M. The largest seller was Wellington Management Group, cutting an estimated $115M.

  • 257 institutional investors held Akero Therapeutics (AKRO) as of Q2 2025, up from 240 in Q1 2025.
  • Funds reported $4.92B of Akero Therapeutics stock for Q2 2025, up 40% quarter-over-quarter.
  • 57 funds opened new Akero Therapeutics positions in Q2 2025 and 39 closed out, a net change of +18 holders.
  • The largest Akero Therapeutics buyer in Q2 2025 was Avoro Capital Advisors, an estimated $159M added.
  • The largest Akero Therapeutics seller in Q2 2025 was Wellington Management Group, an estimated $115M sold.

Based on aggregated 13F filings for Q2 2025.